Across North America in 2025, public policy toward nicotine pouches and other non-combustible, smoke-free products revealed a stark divergence in regulatory philosophy.In Canada, federal and ...

In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thinners among ...

VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha in High-Risk Patients, with Median 44 mg/dL LDL-C Achieved THOUSAND OAKS, Calif., March 28, 2026 /PRNewswire/ -- Amgen ...

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha ...

Background High-dose folic acid supplementation is recommended for women using antiseizure medication (ASMs) to reduce risk of major congenital anomalies (MCAs) in offspring, but evidence is lacking.

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage ...

Apixaban and rivaroxaban are the oral anticoagulants most frequently used to treat acute venous thromboembolism. However, uncertainty remains about the difference in bleeding risk between the two ...

For patients with type 2 diabetes, a new study reinforces the importance of adhering to a healthy lifestyle even when taking a glucagon-like peptide-1 (GLP-1) receptor agonist. Patients who combined a ...

When individuals were presented with risk and benefit information about statins, they required 50-75% relative reduction in risk in order to find taking a statin acceptable. Statins provide a 25% ...

Please provide your email address to receive an email when new articles are posted on . Urate-lowering treatment reduced the 5-year risk for major adverse cardiovascular events for patients with gout.

Seres Therapeutics sold VOWST to Nestlé in 2024. This helped validate their microbiome therapeutics. This sale also helped them extend their runway into Q2 2026 after a 25% workforce reduction. Their ...

Background: The PFO-Associated Stroke Causal Likelihood (PASCAL) classification is a prospectively validated decision-making guide regarding PFO closure to prevent recurrent stroke. The algorithm ...